PP
NARI

PDT Partners’s Inari Medical, Inc. Common Stock NARI Stock Holding History

PDT Partners’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-21,901
Closed -$1.42M – 699
2023
Q4 		$1.42M Sell
21,901
-16,410
-43% -$988K 0.16% 224
2023
Q3 		$2.51M Sell
38,311
-7,983
-17% -$502K 0.32% 97
2023
Q2 		$2.69M Buy
46,294
+9,819
+27% +$619K 0.37% 70
2023
Q1 		$2.25M Buy
36,475
+28,170
+339% +$1.69M 0.31% 110
2022
Q4 		$528K Sell
8,305
-12,722
-61% -$922K 0.09% 373
2022
Q3 		$1.53M Buy
21,027
+5,122
+32% +$381K 0.23% 112
2022
Q2 		$1.08M Sell
15,905
-27,855
-64% -$2M 0.1% 370
2022
Q1 		$3.97M Sell
43,760
-7,691
-15% -$630K 0.34% 52
2021
Q4 		$4.7M Sell
51,451
-8,398
-14% -$720K 0.36% 60
2021
Q3 		$4.85M Buy
59,849
+10,972
+22% +$922K 0.35% 78
2021
Q2 		$4.56M Buy
48,877
+45,677
+1,427% +$4.43M 0.3% 123
2021
Q1 		$342K Buy
+3,200
New +$332K 0.02% 588

Other funds holding NARI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

PDT Partners's NARI Position: Q1 2024 in Review

PDT Partners sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2024, closing a stake of 21,901 shares — an estimated $1.42M sold.

PDT Partners first reported a position in NARI in Q1 2021 and held it in 12 quarters. The position peaked at $4.85M in Q3 2021. 231 funds tracked by Wall St. Rank hold NARI as of Q1 2024.

  • PDT Partners reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • PDT Partners sold 21,901 Inari Medical, Inc. Common Stock shares in Q1 2024, an estimated $1.42M.
  • PDT Partners first reported a position in Inari Medical, Inc. Common Stock in Q1 2021 and held it in 12 quarters.
  • PDT Partners's Inari Medical, Inc. Common Stock position peaked at $4.85M in Q3 2021.
  • 231 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2024.

Based on PDT Partners's 13F filing for Q1 2024, filed 15 May 2024.